Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.

Protein and peptide letters - 1 Jan 2012

Cai Lai, Huang Wei, Chou Kuo-Chen

Abstract excerpt

Both CYP17 and UGT2B17 are suggested to be potential risk factors of prostate cancer (PCa). To date, many studies have evaluated the relationship between CYP17 T-34C and UGT2B17 Del polymorphisms and Prostate cancer with conflicting results. Here, we performed comprehensive meta-analyses of over 25 studies, including results from about 17,000 subjects on the association of CYP17 T-34C and UGT2B17 Del...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Databases, Bibliographic
Share to Glucuronosyltransferase
Share to Minor Histocompatibility Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Odds Ratio

Share to Promoter Regions, Genetic

Share to Prostatic Neoplasms

Share to Sequence Deletion

Share to Steroid 17-alpha-Hydroxylase

Source

Identifiers

PMID: 21919858
DOI: 10.2174/092986612798472848

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.PMID 21919858Read ↗

Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.Semantic proximity Read ↗

Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies.Semantic proximity Read ↗

CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.Semantic proximity Read ↗

Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.Semantic proximity Read ↗

CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis.Semantic proximity Read ↗

The role of CYP17A1 in prostate cancer development: structure, function, mechanism of action, genetic variations and its inhibition.Semantic proximity Read ↗

A polymorphism in the CYP17 gene and risk of prostate cancer.Semantic proximity Read ↗

CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

No association of the 5' promoter region polymorphism of CYP17 gene with prostate cancer risk.Semantic proximity Read ↗

Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.